skip to content
Infliximab : pharmacology, uses and limitations Preview this item
ClosePreview this item
Checking...

Infliximab : pharmacology, uses and limitations

Author: Antonio D Medrano Acevedo; Montserrat Fajardo Gaitan
Publisher: New York : Nova Science Publishers, [2012] ©2012.
Series: Immunology and immune system disorders.; Pharmacology-research, safety testing, and regulation series.
Edition/Format:   eBook : Document : EnglishView all editions and formats
Database:WorldCat
Rating:

(not yet rated) 0 with reviews - Be the first.

Subjects
More like this

 

Find a copy online

Links to this item

Find a copy in the library

&AllPage.SpinnerRetrieving; Finding libraries that hold this item...

Details

Genre/Form: Electronic books
Additional Physical Format: Print version:
Material Type: Document, Internet resource
Document Type: Internet Resource, Computer File
All Authors / Contributors: Antonio D Medrano Acevedo; Montserrat Fajardo Gaitan
ISBN: 1619423456 9781619423459
OCLC Number: 961573436
Notes: "Nova biomedical."
Description: 1 online resource (xiv, 188 pages) illustrations.
Contents: ""INFLIXIMAB PHARMACOLOGY, USES AND LIMITATIONS ""; ""INFLIXIMAB PHARMACOLOGY, USES AND LIMITATIONS ""; ""Contents ""; ""Preface ""; ""The Risk of Infection in Patients Treated with Infliximab ""; ""Abstract ""; ""1. Definition and Functions of Tumour Necrosis Factor ""; ""2. Anti-TNF Mechanism of Action: Infliximab ""; ""3. Risk of Infections in the Use of Infliximab: Evidence""; ""4. Risk of Infection from the Use of Anti-TNF (Inflximab): Mechanisms Involved""; ""5. Other Risk Factors for Infection in Patients Treated with Infliximab ""; ""6. Infections ""; ""Bacterial Infections"" ""Listeria """"Tuberculosis ""; ""Virus ""; ""Fungal Infections ""; ""Histoplasmosis ""; ""Coccidioidomycosis ""; ""Cryptococcosis ""; ""Aspergillosis ""; ""Candidiasis""; ""Pneumocystosis ""; ""7. Special Situations""; ""Perisurgical Infections ""; ""Hepatitis B Virus Infection ""; ""Hepatitis C Virus Infection ""; ""HIV Infection ""; ""Vaccines ""; ""Conclusions ""; ""References ""; ""Infliximab in Inflammatory Bowel Disease ""; ""Abstract ""; ""Pharmacology""; ""Uses ""; ""Inflammatory Crohnâ€?s Disease ""; ""Fistulizing Crohnâ€?s Disease ""; ""Ulcerative Colitis""; ""Mucosal Healing "" ""Pouchitis""""Extraintestinal Manifestations ""; ""Limitations ""; ""Predictors of Response to Infliximab ""; ""Infections ""; ""Malignancies and Lymphoma ""; ""Cutaneous, Neurological and Liver Manifestations ""; ""Congestive Heart Failure ""; ""Pregnancy ""; ""References ""; ""Infliximab: Up-to-Date on Indications and Warnings ""; ""Abstract ""; ""1. Introduction""; ""2. Pharmacology""; ""2.1. Structure and Mechanisms of Action""; ""2.2. Absorption ""; ""2.3. Distribution ""; ""2.4. Metabolism and Excretion ""; ""2.5. Dosage and Administration ""; ""2.6. Pharmacogenomics"" ""2.7. Drug Interactions """"3. Clinical Uses ""; ""3.1. Autoimmune Conditions ""; ""a) Psoriatic Arthritis ""; ""b) Rheumatoid Arthritis ""; ""c) Ulcerative colitis (UC)""; ""d) Crohnâ€?s Disease (CD)""; ""e) Ankylosing Spondylitis""; ""f) Sarcoidosis""; ""g) BehÃet Disease""; ""h) Polychondritis""; ""i) Giant Cell Arteritis ""; ""j) Sjögren Syndrome ""; ""k) Juvenile Idiopathic Arthritis (JIA)""; ""l) Eosinophilic Fasciitis ""; ""3.2. Dermatological Conditions ""; ""A) Toxic Epidermic Necrolysis""; ""B) Subcorneal Pustular Dermatosis ""; ""C) Pyoderma Gangrenosum "" ""D) Chronic Eczema """"E) Hidradenitis Susppurativa (HS) ""; ""3.3. Other Verified Uses ""; ""a) SAPHO Syndrome ""; ""b) Kawasaki Disease ""; ""c) Pulmonary Fibrosis ""; ""d) Cap Polyposis ""; ""e) Postresuscitation Myocardial Dysfunction ""; ""f) B-Chronic Lymphocytic Leukemia ""; ""g) Diabetic Macular Edema ""; ""4. Warnings and Limitations""; ""4.1. Serious Infections ""; ""4.2. Malignancies ""; ""4.3. Hepatitis B virus Reactivation ""; ""4.4. Hepatotoxicity ""; ""4.5. Patients with Heart Failure ""; ""4.6. Hematological and Vascular Events ""; ""4.7. Hypersensitivity ""
Series Title: Immunology and immune system disorders.; Pharmacology-research, safety testing, and regulation series.
Responsibility: Antonio D. Medrano Acevedo and Montserrat Fajardo Gaitan, editors.

Reviews

User-contributed reviews
Retrieving GoodReads reviews...
Retrieving DOGObooks reviews...

Tags

Be the first.
Confirm this request

You may have already requested this item. Please select Ok if you would like to proceed with this request anyway.

Linked Data


Primary Entity

<http://www.worldcat.org/oclc/961573436> # Infliximab : pharmacology, uses and limitations
    a schema:MediaObject, schema:CreativeWork, schema:Book ;
    library:oclcnum "961573436" ;
    library:placeOfPublication <http://id.loc.gov/vocabulary/countries/nyu> ;
    schema:about <http://experiment.worldcat.org/entity/work/data/1208837686#Topic/anti_inflammatory_agents> ; # Anti-inflammatory agents
    schema:about <http://experiment.worldcat.org/entity/work/data/1208837686#Topic/infliximab_therapeutic_use> ; # Infliximab--Therapeutic use
    schema:about <http://experiment.worldcat.org/entity/work/data/1208837686#Topic/medical_immunology> ; # MEDICAL--Immunology
    schema:about <http://experiment.worldcat.org/entity/work/data/1208837686#Topic/autoimmune_diseases_chemotherapy> ; # Autoimmune diseases--Chemotherapy
    schema:about <http://experiment.worldcat.org/entity/work/data/1208837686#Topic/infliximab> ; # Infliximab
    schema:about <http://experiment.worldcat.org/entity/work/data/1208837686#Topic/autoimmune_diseases_drug_therapy> ; # Autoimmune Diseases--drug therapy
    schema:about <http://dewey.info/class/616.978061/e23/> ;
    schema:bookFormat schema:EBook ;
    schema:datePublished "2012" ;
    schema:description """INFLIXIMAB PHARMACOLOGY, USES AND LIMITATIONS ""; ""INFLIXIMAB PHARMACOLOGY, USES AND LIMITATIONS ""; ""Contents ""; ""Preface ""; ""The Risk of Infection in Patients Treated with Infliximab ""; ""Abstract ""; ""1. Definition and Functions of Tumour Necrosis Factor ""; ""2. Anti-TNF Mechanism of Action: Infliximab ""; ""3. Risk of Infections in the Use of Infliximab: Evidence""; ""4. Risk of Infection from the Use of Anti-TNF (Inflximab): Mechanisms Involved""; ""5. Other Risk Factors for Infection in Patients Treated with Infliximab ""; ""6. Infections ""; ""Bacterial Infections"""@en ;
    schema:editor <http://experiment.worldcat.org/entity/work/data/1208837686#Person/fajardo_gaitan_montserrat> ; # Montserrat Fajardo Gaitan
    schema:editor <http://experiment.worldcat.org/entity/work/data/1208837686#Person/medrano_acevedo_antonio_d> ; # Antonio D. Medrano Acevedo
    schema:exampleOfWork <http://worldcat.org/entity/work/id/1208837686> ;
    schema:genre "Electronic books"@en ;
    schema:inLanguage "en" ;
    schema:isPartOf <http://experiment.worldcat.org/entity/work/data/1208837686#Series/pharmacology_research_safety_testing_and_regulation_series> ; # Pharmacology-research, safety testing, and regulation series.
    schema:isPartOf <http://experiment.worldcat.org/entity/work/data/1208837686#Series/immunology_and_immune_system_disorders> ; # Immunology and immune system disorders.
    schema:isPartOf <http://experiment.worldcat.org/entity/work/data/1208837686#Series/pharmacology_research_safety_testing_and_regulation> ; # Pharmacology-research, safety testing and regulation
    schema:isSimilarTo <http://worldcat.org/entity/work/data/1208837686#CreativeWork/> ;
    schema:name "Infliximab : pharmacology, uses and limitations"@en ;
    schema:productID "961573436" ;
    schema:url <http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=540914> ;
    schema:url <http://site.ebrary.com/id/10654918> ;
    schema:url <http://public.eblib.com/choice/publicfullrecord.aspx?p=3017947> ;
    schema:workExample <http://worldcat.org/isbn/9781619423459> ;
    wdrs:describedby <http://www.worldcat.org/title/-/oclc/961573436> ;
    .


Related Entities

<http://experiment.worldcat.org/entity/work/data/1208837686#Person/fajardo_gaitan_montserrat> # Montserrat Fajardo Gaitan
    a schema:Person ;
    schema:familyName "Fajardo Gaitan" ;
    schema:givenName "Montserrat" ;
    schema:name "Montserrat Fajardo Gaitan" ;
    .

<http://experiment.worldcat.org/entity/work/data/1208837686#Person/medrano_acevedo_antonio_d> # Antonio D. Medrano Acevedo
    a schema:Person ;
    schema:familyName "Medrano Acevedo" ;
    schema:givenName "Antonio D." ;
    schema:name "Antonio D. Medrano Acevedo" ;
    .

<http://experiment.worldcat.org/entity/work/data/1208837686#Series/immunology_and_immune_system_disorders> # Immunology and immune system disorders.
    a bgn:PublicationSeries ;
    schema:hasPart <http://www.worldcat.org/oclc/961573436> ; # Infliximab : pharmacology, uses and limitations
    schema:name "Immunology and immune system disorders." ;
    schema:name "Immunology and immune system disorders" ;
    .

<http://experiment.worldcat.org/entity/work/data/1208837686#Series/pharmacology_research_safety_testing_and_regulation> # Pharmacology-research, safety testing and regulation
    a bgn:PublicationSeries ;
    schema:hasPart <http://www.worldcat.org/oclc/961573436> ; # Infliximab : pharmacology, uses and limitations
    schema:name "Pharmacology-research, safety testing and regulation" ;
    .

<http://experiment.worldcat.org/entity/work/data/1208837686#Series/pharmacology_research_safety_testing_and_regulation_series> # Pharmacology-research, safety testing, and regulation series.
    a bgn:PublicationSeries ;
    schema:hasPart <http://www.worldcat.org/oclc/961573436> ; # Infliximab : pharmacology, uses and limitations
    schema:name "Pharmacology-research, safety testing, and regulation series." ;
    .

<http://experiment.worldcat.org/entity/work/data/1208837686#Topic/anti_inflammatory_agents> # Anti-inflammatory agents
    a schema:Intangible ;
    schema:name "Anti-inflammatory agents"@en ;
    .

<http://experiment.worldcat.org/entity/work/data/1208837686#Topic/autoimmune_diseases_chemotherapy> # Autoimmune diseases--Chemotherapy
    a schema:Intangible ;
    schema:name "Autoimmune diseases--Chemotherapy"@en ;
    .

<http://experiment.worldcat.org/entity/work/data/1208837686#Topic/autoimmune_diseases_drug_therapy> # Autoimmune Diseases--drug therapy
    a schema:Intangible ;
    schema:name "Autoimmune Diseases--drug therapy"@en ;
    .

<http://experiment.worldcat.org/entity/work/data/1208837686#Topic/infliximab_therapeutic_use> # Infliximab--Therapeutic use
    a schema:Intangible ;
    schema:name "Infliximab--Therapeutic use"@en ;
    .

<http://experiment.worldcat.org/entity/work/data/1208837686#Topic/medical_immunology> # MEDICAL--Immunology
    a schema:Intangible ;
    schema:name "MEDICAL--Immunology"@en ;
    .

<http://worldcat.org/entity/work/data/1208837686#CreativeWork/>
    a schema:CreativeWork ;
    schema:description "Print version:" ;
    schema:isSimilarTo <http://www.worldcat.org/oclc/961573436> ; # Infliximab : pharmacology, uses and limitations
    .

<http://worldcat.org/isbn/9781619423459>
    a schema:ProductModel ;
    schema:isbn "1619423456" ;
    schema:isbn "9781619423459" ;
    .


Content-negotiable representations

Close Window

Please sign in to WorldCat 

Don't have an account? You can easily create a free account.